Treatment with a pharmaceutical formulation of cannabidiol alongside other anti-epilepsy treatments helped to reduce the number of drop seizures — seizures which involve sudden falls due to loss of muscle tone — in people with Lennox-Gastaut syndrome who did not respond to previous treatment, according to a recent phase 3 randomized clinical trial.